Dysphagia Therapy
Like No Other

Non-surgical, neurostimulation therapy
to restore swallowing control and reduce length of stay.

Dysphagia Therapy
Like No Other

Non-surgical, neurostimulation therapy
to restore swallowing control and reduce length of stay.

Dysphagia Therapy
Like No Other

Non-surgical, neurostimulation therapy
to restore swallowing control and reduce length of stay.

Targeting and restoring the neurological components of swallowing coordination and control that are disrupted due to brain injury or prolonged mechanical ventilation.

Dysphagia is Common, Costly,
and Harmful to Patients​

Dysphagia is Common, Costly, and Harmful to Patients​

Swallowing impairment, called dysphagia, affects millions of people worldwide and can have a profound health and economic impact.

Extended
Hospital Stay
High Burden
of Care
Poor Quality
of Life
Treating the Root Cause of Dysphagia.
Phagenyx® Neurostimulation System

​Introducing the first and only treatment using pharyngeal electrical stimulation (PES) to restore swallowing control, facilitate airway protection, and accelerate recovery.​

Personalized levels of PES, delivered at the earliest stages after injury, enhance neurorehabilitation and reorganization of swallowing control, while requiring minimal patient participation.

Video Duration: 02:40
Video Duration: 05:50

Simple & Safe

Non-surgical therapy with 10+ years of clinical use in Europe
1

Adjust the catheter to reflect patient anatomy and then insert. When ready to deliver treatment, connect the catheter to the Base Station.

2

Follow Base Station on-screen instructions to measure patient sensory capacity and optimize the stimulation level

3

Deliver optimized stimulation for 10 minutes once per day. On completion, disconnect the Base Station. Leave the catheter in place.

4

Repeat for 3-6 days as clinically indicated. On completion of the treatment regimen, remove the catheter or leave in place for feeding for up to 30 days

Extensive Clinical Evidence
Demonstrated Safety in Multiple Patient Populations
Years
0 +
Randomized
Control Trials
0 +
Publications
0 +
Founded in 2007, Phagenesis is committed to scientific and clinical excellence in the development of novel therapies to treat patients suffering from neurogenic dysphagia.
The foundational science and clinical evidence for the pharyngeal electrical stimulation used in Phagenyx, has been peer reviewed and published at the highest level.

REINHARD KRICKL

Chief Executive Officer

CONOR MULROONEY

Co-Founder & Chief Operating Officer

TARJA BARNES

Chief Financial Officer

SHAHEEN HAMDY

Co-Founder & Chief Scientific Officer

PETER LUCKS

Director European Sales

SCOTT GRANT

VP US Therapy Development

ANIL KENI

VP Global Marketing

CLAIRE COLLINS

Head of Human Resources

CARI MANYPENNY

Head of Global Education

SATISH MISTRY

Head of Clinical Operations

OERN STUGE

Chairperson, Director

Chairperson Orsco Lifesciences AG
FRED EDENIUS

Director

Founder / Director Scientific Venture Partners
MICHEL GARDET

Director

Representing Nestle Health Sciences
SHAHEEN HAMDY

Director

Co Founder Phagenesis Director
GUNNAR WEIKERT

Director

Chairman and Founder Investages
AUGUST 15, 2023

|

Press Release

Arizona chef able to swallow again thanks to new therapy used to treat stroke patients at Banner – University Medical Center Phoenix

Hospital is one of the first three facilities in the country using the Phagenyx™ Neurostimulation System

PHOENIX (Aug. 15, 2023) – 55-year-old Michael John Coe of Prescott Valley never thought much about his ability to swallow until he was forced to re-learn this essential function after suffering three strokes recently. Coe, who works professionally as a chef and baker, was the second patient at Banner – University Medical Center Phoenix to benefit from a new therapy called pharyngeal electrical stimulation, or PES, which is delivered via the Phagenyx Neurostimulation System. Phagenyx helps patients with dysphagia, a common condition following stroke, to regain their swallowing function and ability to eat and drink.

Phagenyx PES therapy works by utilizing a specialized catheter with built-in electrodes that provide small electrical pulses to stimulate critical sensory nerves within the throat (pharynx), shown to reestablish communication between these nerves and the brain. The treatment lasts for ten minutes per day for at least three and up to six days. The therapy is carried out by speech pathologists based on their assessment and is another important tool they use to help patients regain swallowing function.

Get more information

For more information about Phagenesis or the Phagenyx System, please complete the form below.

Come work with us

We are looking for new talent to fuel our next stage of growth. If you are interested in joining our dynamic team, reach out to us at jobs@phagenesis.com or view our open positions on LinkedIn.

Get more information

For more information about Phagenesis or the Phagenyx System, please complete the form below.

Come work with us

We are looking for new talent to fuel our next stage of growth. If you are interested in joining our dynamic team, reach out to us at jobs@phagenesis.com or view our open positions on LinkedIn.

Get more information

For more information about Phagenesis or the Phagenyx System, please complete the form below.

Come work with us

We are looking for new talent to fuel our next stage of growth. If you are interested in joining our dynamic team, reach out to us at jobs@phagenesis.com or view our open positions on LinkedIn.